Green Cross Medical Science Balance Sheet Health
Financial Health criteria checks 2/6
Green Cross Medical Science has a total shareholder equity of ₩38.1B and total debt of ₩23.2B, which brings its debt-to-equity ratio to 60.8%. Its total assets and total liabilities are ₩95.4B and ₩57.3B respectively. Green Cross Medical Science's EBIT is ₩370.3M making its interest coverage ratio 0.1. It has cash and short-term investments of ₩6.5B.
Key information
60.8%
Debt to equity ratio
₩23.16b
Debt
| Interest coverage ratio | 0.1x |
| Cash | ₩6.47b |
| Equity | ₩38.11b |
| Total liabilities | ₩57.29b |
| Total assets | ₩95.40b |
Recent financial health updates
Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?
Aug 30
These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively
Feb 24Recent updates
Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?
Aug 30There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise
Aug 08We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated
Mar 26Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings
Mar 23These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively
Feb 24Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?
Jan 28Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?
Jan 02Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?
Dec 07Financial Position Analysis
Short Term Liabilities: A142280's short term assets (₩47.4B) do not cover its short term liabilities (₩49.3B).
Long Term Liabilities: A142280's short term assets (₩47.4B) exceed its long term liabilities (₩7.9B).
Debt to Equity History and Analysis
Debt Level: A142280's net debt to equity ratio (43.8%) is considered high.
Reducing Debt: A142280's debt to equity ratio has reduced from 606.6% to 60.8% over the past 5 years.
Debt Coverage: A142280's debt is not well covered by operating cash flow (16.2%).
Interest Coverage: A142280's interest payments on its debt are not well covered by EBIT (0.1x coverage).